Mirikizumab

MedChem Express

Mirikizumab

10

Research Use Only

Monoclonal

98.15

Mirikizumab (LY3074828) is a humanized IgG4 monoclonal antibody that targets the p19 subunit of interleukin 23 ( IL-23 ). Mirikizumab binds to human and monkey IL-23 with high affinity, with K d values of 21 pM and 55 pM, respectively. By inhibiting the binding of IL-23 to IL-23R , Mirikizumab modulates the immune response and holds potential for research in ulcerative colitis and Crohns disease [1] [2] .

-80°C

12352203